Pavel Dundr

25PUBLICATIONS
73CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersFoetal development and medicineSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 25, 2026
Immunoreactivity of GPNMB (glycoprotein nonmetastatic melanoma protein B) across the spectrum of uterine mesenchymal tumours.

|Sep 22, 2026
Immunohistochemical expression of p53 is a helpful surrogate marker in the differential diagnosis of primary ovarian mucinous tumors: a large study of 181 cases of mucinous borderline tumor and carcinoma.

|Mar 23, 2026
Folate receptor alpha (FRα) expression in tubo-ovarian and endometrial tumors: a study of 923 cases.

Isabela Töltési, Kristýna Němejcová, Michaela Kendall Bártů

|Mar 10, 2026
Assessment of lymphovascular space invasion in cervical squamous cell carcinoma using digital pathology: a reproducibility study.

Karen L Talia, T Rinda Soong, Takako Kiyokawa

|Jan 28, 2026
CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors.

Pavel Dundr, Eliška Radová, Jan Hojný

|Apr 07, 2025
New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic.

Borek Sehnal, Martin Hruda, Radoslav Matej

Pageof 5

Frequent Collaborators

4 joint publications

David Cibula

4 joint publications

Daniela Fischerova

3 joint publications

A Burgetova

2 joint publications

Radoslav Matěj